Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Depreciation & Amortization

$187.00K

Quarterly · Period ending: · USD

LCTX logo

LCTX Depreciation & Amortization

Latest reported$187.00K
LCTX Quarterly Depreciation & Amortization ($0.00 → $187.00K)
High-resolution chart · PNG

LCTX depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
16,580
19,449
19,328
19,347
18,529
18,254
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.